Effect of Vimentin Protein in Female Iraqi bariatric surgery patients with diabetes mellitus Vimentin Protein in bariatric surgery with diabetes mellitus
Article Sidebar
Main Article Content
Abstract
Obesity has come to be a serious global health risk that can cause a number of chronic, frequently fatal diseases, such as type 2 diabetes and coronary artery disease. Conventional weight-loss approaches such as diet, exercise, and medication typically have relatively poor long-term results. Bariatric surgery is the greatest option for treating patients who are morbidly obese because it allows for substantial, long-term weight loss and improves or resolves obesity-related comorbidities, all of which reduce mortality rates. Vimentin indicate is assessed utilizing thorough cross-sectional research and some biochemical markers. Ninety female blood samples total, divided into three groups, were used in the study. Before BS, group A had type 2 diabetes mellitus (DM) due to obesity; group B was the same group A, however after BS; and group C was the control group. The findings showed that, in comparison to the control group, the patient D.M.'s HbA1c and BMI values increased significantly (P≤0.05) before and after the BS groups. The results also showed that, in all patient groups, the concentrations of urea, creatinine, and uric acid increased significantly. All patient groups showed a considerable rise in vimentin concentration as compared to the control group. This present study led us to the conclusion that vimentin had a noticeable impact on biochemical markers in obese people with pre-diabetes.rese
Article Details
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
The Journal of Medical and Oral Biosciences uses a Creative Commons Attribution (CC Attribution-ShareAlike 4.0) and its license of (CC BY-SA 4.0). This license allows the authors to hold ownership of the copyright of their articles.
Attribution-Share Alike 4.0 International License (CC BY-SA 4.0). 
Under the CC BY-SA 4.0 the authors are free to:
Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
No use, distribution or reproduction is permitted which does not comply with these terms.
https://creativecommons.org/licenses/by-sa/4.0/
References
1. Popoviciu, M.S., L. Paduraru, R.M. Nutas, A.M. Ujoc, G. Yahya, K. Metwally, and S. Cavalu, Diabetes mellitus secondary to endocrine diseases: An update of diagnostic and treatment particularities. International Journal of Molecular Sciences, 2023. 24(16): p. 12676.DOI: org/10.3390/ijms241612676.
2. Ruze, R., T. Liu, X. Zou, J. Song, Y. Chen, R. Xu, X. Yin, and Q. Xu, Obesity and type 2 diabetes mellitus: Connections in epidemiology, pathogenesis, and treatments. Frontiers in endocrinology, 2023. 14: p. 1161521.
3. Zorena, K., O. Jachimowicz-Duda, D. Ślęzak, M. Robakowska, and M. Mrugacz, Adipokines and obesity. Potential link to metabolic disorders and chronic complications. International Journal of Molecular Sciences, 2020. 21(10): p. 3570.
4. Leisegang, K., Oxidative stress in men with obesity, metabolic syndrome and type 2 diabetes mellitus: Mechanisms and management of reproductive dysfunction, in Oxidative stress and toxicity in reproductive biology and medicine: A comprehensive update on male infertility-volume one. 2022, Springer. p. 237-256.
5. Barber, T.M. and S. Franks, Obesity and polycystic ovary syndrome. Clinical Endocrinology, 2021. 95(4): p. 531-541.
6. Li, J.-S., T.-Y. Tsai, M.M. Clancy, G. Li, C.L. Lewis, and D.T. Felson, Weight loss changed gait kinematics in individuals with obesity and knee pain. Gait & posture, 2019. 68: p. 461-465.
7. Martínez-Cenalmor, P., A.E. Martínez, D. Moneo-Corcuera, P. González-Jiménez, and D. Pérez-Sala, Oxidative stress elicits the remodeling of vimentin filaments into biomolecular condensates. Redox Biology, 2024. p. 103282.
8. Kim, S.Y., S.-J. Jeong, J.-H. Park, W. Cho, Y.-H. Ahn, Y.-H. Choi, G.T. Oh, R.L. Silverstein, and Y.M. Park, Plasma membrane localization of cd36 requires vimentin phosphorylation; a mechanism by which macrophage vimentin promotes atherosclerosis. Frontiers in Cardiovascular Medicine, 2022. 9: p. 792717.
9. Roh, E. and H.J. Yoo, The role of adipose tissue lipolysis in diet-induced obesity: Focus on vimentin. Diabetes & Metabolism Journal, 2021. 45(1): p. 43-45.
10. Shen, W.-J., S. Patel, J.E. Eriksson, and F.B. Kraemer, Vimentin is a functional partner of hormone sensitive lipase and facilitates lipolysis. Journal of proteome research, 2010. 9(4): p. 1786-1794.
11. Nilsson, M.B., X. Le, and J.V. Heymach, Β-adrenergic signaling in lung cancer: A potential role for beta-blockers. Journal of Neuroimmune Pharmacology, 2020. 15: p. 27-36.
12. Ridge, K.M., J.E. Eriksson, M. Pekny, and R.D. Goldman, Roles of vimentin in health and disease. Genes & development, 2022. 36(7-8): p. 391-407.
13. McArdle, W.D., F.I. Katch, and V.L. Katch, Essentials of exercise physiology.2006: Lippincott Williams & Wilkins.
14. Lopez-Gonzalez, D., A. Partida-Gaytán, J.C. Wells, P. Reyes-Delpech, F. Avila-Rosano, M. Ortiz-Obregon, F. Gomez-Mendoza, L. Diaz-Escobar, and P. Clark, Obesogenic lifestyle and its influence on adiposity in children and adolescents, evidence from mexico. Nutrients, 2020. 12(3): p. 819.
15. Peng, M., D. Coutts, T. Wang, and Y.O. Cakmak, Systematic review of olfactory shifts related to obesity. Obesity reviews, 2019. 20(2): p. 325-338.
16. Deledda, A., G. Annunziata, G.C. Tenore, V. Palmas, A. Manzin, and F. Velluzzi, Diet-derived antioxidants and their role in inflammation, obesity and gut microbiota modulation. Antioxidants, 2021. 10(5): p. 708.
17. Belfort-DeAguiar, R. and D. Seo, Food cues and obesity: Overpowering hormones and energy balance regulation. Current obesity reports, 2018. 7: p. 122-129.
18. Pasquali, R., F. Casanueva, M. Haluzik, L. Van Hulsteijn, S. Ledoux, M. Monteiro, J. Salvador, F. Santini, H. Toplak, and O. Dekkers, European society of endocrinology clinical practice guideline: Endocrine work-up in obesity. European Journal of Endocrinology, 2020. 182(1): p. G1-G32.
19. Fernandez-Garcia, J.C., J. Alcaide, C. Santiago-Fernandez, M. Roca-Rodriguez, Z. Aguera, R. Baños, C. Botella, R. De la Torre, J.M. Fernandez-Real, and G. Fruhbeck, An increase in visceral fat is associated with a decrease in the taste and olfactory capacity. PloS one, 2017. 12(2): p. e0171204.
20. Stafford, L.D. and A. Whittle, Obese individuals have higher preference and sensitivity to odor of chocolate. Chemical senses, 2015. 40(4): p. 279-284.
21. Mahdavi, M., A. Amouzegar, L. Mehran, E. Madreseh, M. Tohidi, and F. Azizi, Investigating the prevalence of primary thyroid dysfunction in obese and overweight individuals: Tehran thyroid study. BMC Endocrine Disorders, 2021. 21(1): p. 1-12.
22. Muscogiuri, G., L. Barrea, S. Aprano, L. Framondi, R. Di Matteo, D. Laudisio, G. Pugliese, S. Savastano, A. Colao, and O.P. Project, Chronotype and adherence to the mediterranean diet in obesity: Results from the opera prevention project. Nutrients, 2020. 12(5): p. 1354.
23. Palmas, V., S. Pisanu, V. Madau, E. Casula, A. Deledda, R. Cusano, P. Uva, S. Vascellari, A. Loviselli, and A. Manzin, Gut microbiota markers associated with obesity and overweight in italian adults. Scientific reports, 2021. 11(1): p. 1-14.
24. Mohapatra, S., K. Gangadharan, and C.S. Pitchumoni, Malnutrition in obesity before and after bariatric surgery. Disease-a-month, 2020. 66(2): p. 100866.
25. El Ansari, W. and W. Elhag, Weight regain and insufficient weight loss after bariatric surgery: Definitions, prevalence, mechanisms, predictors, prevention and management strategies, and knowledge gaps—a scoping review. Obesity Surgery, 2021. 31: p. 1755-1766.
26. Istfan, N.W., M. Lipartia, W.A. Anderson, D.T. Hess, and C.M. Apovian, Approach to the patient: Management of the post–bariatric surgery patient with weight regain. The Journal of Clinical Endocrinology & Metabolism, 2021. 106(1): p. 251-263.
27. Chooi, Y.C., C. Ding, and F. Magkos, The epidemiology of obesity. Metabolism, 2019. 92: p. 6-10.
28. Jaacks, L.M., S. Vandevijvere, A. Pan, C.J. McGowan, C. Wallace, F. Imamura, D. Mozaffarian, B. Swinburn, and M. Ezzati, The obesity transition: Stages of the global epidemic. The lancet Diabetes & endocrinology, 2019. 7(3): p. 231-240.
29. Bettini, S., A. Belligoli, R. Fabris, and L. Busetto, Diet approach before and after bariatric surgery. Reviews in Endocrine and Metabolic Disorders, 2020. 21: p. 297-306.
30. Hu, F. and T. Zhang, Study on risk factors of diabetic nephropathy in obese patients with type 2 diabetes mellitus. International journal of general medicine, 2020. p. 351-360.
31. Lu, H.-Y., X.-Y. Ning, Y.-Q. Chen, S.-J. Han, P. Chi, S.-N. Zhu, and Y. Yue, Predictive value of serum creatinine, blood urea nitrogen, uric acid, and β 2-microglobulin in the evaluation of acute kidney injury after orthotopic liver transplantation. Chinese medical journal, 2018. 131(09): p. 1059-1066.
32. Heid, H., S. Rickelt, R. Zimbelmann, S. Winter, H. Schumacher, Y. Dörflinger, C. Kuhn, and W.W. Franke, On the formation of lipid droplets in human adipocytes: The organization of the perilipin–vimentin cortex. PloS one, 2014. 9(2): p. e90386.
33. Hirata, Y., T. Hosaka, T. Iwata, C.T. Le, B. Jambaldorj, K. Teshigawara, N. Harada, H. Sakaue, T. Sakai, and K. Yoshimoto, Vimentin binds irap and is involved in glut4 vesicle trafficking. Biochemical and Biophysical Research Communications, 2011. 405(1): p. 96-101.
34. Hussain, A., I. Ali, W.A. Kaleem, and F. Yasmeen, Correlation between body mass index and lipid profile in patients with type 2 diabetes attending a tertiary care hospital in peshawar. Pakistan journal of medical sciences, 2019. 35(3): p. 591.
35. Zapolski, T., P. Waciński, B. Kondracki, E. Rychta, M.J. Buraczyńska, and A. Wysokiński, Uric acid as a link between renal dysfunction and both pro-inflammatory and prothrombotic state in patients with metabolic syndrome and coronary artery disease. Kardiologia Polska (Polish Heart Journal), 2011. 69(4): p. 319-326.
36. Nugraha, R., N. Tristina, and M. Miftanurachman, Correlation between serum uric acid and hba1c levels in patients with type 2 diabetes mellitus. Althea Medical Journal, 2018. 5(3): p. 142-145.